PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+35.25%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.54B
AUM Growth
+$3.54B
(+35%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
51.45%
Holding
126
New
23
Increased
26
Reduced
8
Closed
24
Top Buys
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$103M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$76.1M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$34.6M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$33.1M |
| 5 |
Regenxbio
RGNX
|
$28.7M |
Top Sells
| 1 |
Solid Biosciences
SLDB
|
$105M |
| 2 |
Neurocrine Biosciences
NBIX
|
$74.9M |
| 3 |
argenx
ARGX
|
$53.9M |
| 4 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$41M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$39.9M |
Sector Composition
| 1 | Healthcare | 92.52% |
| 2 | Financials | 0.51% |
| 3 | Technology | 0.04% |
| 4 | Consumer Discretionary | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Neurocrine Biosciences
NBIX
$13.8B
| $331M | 9.34% | 3,758,662 -849,892 | -18% | -$74.9M |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $294M | 8.3% | 21,639,486 +915,062 | +4% | +$12.4M |
|
|
GBT
3
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $292M | 8.25% | 5,525,726 +100,000 | +2% | +$5.29M |
|
|
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
| $213M | 6.01% | 3,869,491 +79,275 | +2% | +$4.36M |
|
|
AMRN
5
Amarin Corp
AMRN
$311M
| $136M | 3.83% | 6,540,957 +1,665,357 | +34% | +$34.6M |
|
6
Ascendis Pharma
ASND
$11.8B
| $131M | 3.7% | 1,113,328 +60,681 | +6% | +$7.14M |
|
7
Iovance Biotherapeutics
IOVA
$807M
| $116M | 3.28% | 12,235,811 -5,300 | -0% | -$50.4K |
|
8
MeiraGTx Holdings
MGTX
$587M
| $104M | 2.92% | 6,007,746 +1,304,348 | +28% | +$22.5M |
|
|
ARRY
9
DELISTED
Array Biopharma Inc
ARRY
| $103M | 2.91% | +4,228,900 | New | +$103M |
|
|
BPMC
10
DELISTED
Blueprint Medicines
BPMC
| $102M | 2.87% | 1,271,054 +413,728 | +48% | +$33.1M |
|
|
QTNT
11
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $97.2M | 2.74% | 10,789,054 | – | – |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $85.3M | 2.41% | 1,164,382 +1,038,507 | +825% | +$76.1M |
|
13
Travere Therapeutics
TVTX
$1.56B
| $69.1M | 1.95% | 3,054,707 -287,331 | -9% | -$6.5M |
|
|
14
Regenxbio
RGNX
$451M
| $65.7M | 1.85% | 1,145,726 +500,000 | +77% | +$28.7M |
|
15
Merit Medical Systems
MMSI
$5.36B
| $65.1M | 1.84% | 1,053,098 +103,900 | +11% | +$6.42M |
|
|
ARNA
16
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $62.8M | 1.77% | 1,400,171 -30,000 | -2% | -$1.34M |
|
|
ATNX
17
DELISTED
Athenex, Inc. Common Stock
ATNX
| $62.4M | 1.76% | 5,096,022 | – | – |
|
18
Crinetics Pharmaceuticals
CRNX
$2.92B
| $58.9M | 1.66% | 2,587,953 | – | – |
|
|
CBAY
19
DELISTED
Cymabay Therapeutics
CBAY
| $55.9M | 1.58% | 4,212,821 +1,750,000 | +71% | +$23.2M |
|
|
ALBO
20
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $54.9M | 1.55% | 1,704,330 | – | – |
|
|
MYOK
21
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $51.4M | 1.45% | 988,511 -86,705 | -8% | -$4.51M |
|
|
NVTA
22
DELISTED
Invitae Corporation
NVTA
| $50.9M | 1.44% | 2,171,918 +308,512 | +17% | +$7.23M |
|
23
Allogene Therapeutics
ALLO
$251M
| $44.6M | 1.26% | 1,543,790 | – | – |
|
|
VBIV
24
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $42.6M | 1.2% | 23,951,556 | – | – |
|
|
MNTA
25
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $41.8M | 1.18% | 2,875,000 +50,000 | +2% | +$727K |
|